We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BODITECH

Boditech Med Inc. develops products for in-vitro diagnostics and diagnostic reagents. Its products include automatic ... read more Featured Products: More products

Download Mobile App





Boditech Launches New Automated Immunoassay Analyzer with Blood Collection Tube at MEDICA 2021

By LabMedica International staff writers
Posted on 15 Nov 2021

Boditech Med (Gang-won-do, Korea) has launched its new automated immunoassay analyzer with blood collection tube, including an all-in-one cartridge system, at MEDICA 2021. More...

Boditech’s new POC immunoassay analyzer, AFIAS-10, is a unique integrated Sample-to-Answer system that can execute 10 parallel tests for each different parameter. AFIAS-10 provides a quick and simplified operation and reliable test result with automatically collecting a sample from a blood tube. Boditech showcased its range of parameters that can be executed on the AFIAS-10 covering the areas of cardiac, cancer, diabetes, hormones, infections and autoimmune, among others.

At MEDICA 2021, Boditech also showcased its total solutions for the diagnosis of COVID-19, including ExAmplar COVID-19 real-time PCR kit which comes in ready-to-use mixture and the user can use the reagent without mixing ingredients; the ExAmplex Influenza A/B SARS-CoV-2 PCR kit for the simultaneous PCR detection of COVID-19 and Influenza A/B; and the ExAmplex COVID-19 PCR 3-gene kit which detects two COVID-19 confirmation genes, and one Pan-corona gene with high accuracy.

Among other products, Boditech highlighted its ExAmplar compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges. ExAmplar employs relatively fast thermal cycles (~40 sec) and can deliver the DNA and RNA test results in 30 and 45~55 minutes, respectively. The system runs with dedicated 8-well plates. The reagents for the test come in a dry format, which one can store at room temperature. In addition, Boditech demonstrated the NuActor bench-top & automated nucleic acid (RNA/DNA) extraction system. NuActor is an automated nucleic acid extraction system, used with a ready-to-use cartridge that can be stored at room temperature as a table-top extractor. It can extract concentrated high-purity nucleic acids from a small volume of samples such as blood, cultured cells, and animal tissues quickly and easily.

Related Links:
Boditech Med 


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
Portable POCT Blood Gas Analyzer
BD100
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Illustration of the new blood test, which uses a DNA chip to detect the tumor’s biological fingerprint (Photo courtesy of Tel Aviv University)

Blood Test on a Chip Offers Low-Cost Lung Cancer Detection Without DNA Sequencing

Lung cancer is the leading cause of cancer deaths worldwide, and screening often yields indeterminate results that prompt invasive workups. Computed tomography (CT) detects small nodules but can flag benign... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Whole-Cell Genomic Analysis Expands the Potential of Liquid Biopsy

Liquid biopsy has expanded access to tumor genomics, but most blood-based assays rely on short, degraded fragments of cell-free circulating tumor DNA (ctDNA). Isolating intact circulating tumor cells from... Read more

Microbiology

view channel
Image: An innovative countywide program in Taiwan combines risk-based screening with decentralized community care to improve hepatitis C detection and treatment (Image Credit: iStock)

Precision Screening Helps Close Hepatitis C Diagnosis and Treatment Gaps

Hepatitis C remains a leading cause of cirrhosis and liver cancer, yet many infections go undiagnosed or untreated because health systems fail to reach those at greatest risk. Although highly effective... Read more

Pathology

view channel
Image: Through the PCCP, Proscia gains a more efficient pathway to expand Concentriq AP-Dx interoperability while maintaining regulatory oversight (Photo courtesy of Proscia)

FDA-Cleared Digital Pathology Platform Expands Interoperability for Primary Diagnosis

Rising cancer incidence is colliding with a shrinking pathologist workforce, intensifying pressure on diagnostic turnaround times in clinical laboratories. Many labs are adopting digital pathology to manage... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.